Intestinal Decarboxylation of Orally Administered L‐dopa
- 12 January 1975
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 198 (1-6) , 415-420
- https://doi.org/10.1111/j.0954-6820.1975.tb19565.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- VARIATION OF LEVODOPA METABOLISM WITH GASTROINTESTINAL-ABSORPTION SITEThe Lancet, 1974
- SUSTAINED-RELEASE LEVODOPAThe Lancet, 1973
- Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's diseaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Plasma Concentration of Levodopa in Patients with Parkinson’s DiseaseEuropean Neurology, 1973
- Decarboxylation of orally administered l-dopa in the human digestive tractNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- Inhibition of L-Phenylalanine Absorption by L-DOPA in Patients with ParkinsonismExperimental Biology and Medicine, 1971
- Urinary Excretion of Histamine, Methylhistamine and Methylimidazoleacetic Acids in Man under Standardized Dietary ConditionsScandinavian Journal of Clinical and Laboratory Investigation, 1968
- Urinary Excretion of Histamine, Methylhistamine and Methylimidazoleacetic Acids in Man under Standardized Dietary ConditionsScandinavian Journal of Clinical and Laboratory Investigation, 1968
- A Method for the Determination of Some Amino Acid DecarboxylasesJournal of Biological Chemistry, 1960